Rapamycin's Human Longevity Efficacy Lacks Evidence
D
Dr. Ben Bikman's video lecture on rapamycin and longevity.
Story of claim
Dr. Ben Bikman critiques rapamycin's role in human longevity, emphasizing the lack of concrete human studies. He suggests the drug's benefits are largely supported by animal studies, with serious side effects like immune suppression.
- Goal: Dr. Bikman aims to highlight the uncertainty of rapamycin's efficacy in extending human lifespan.
- Proof: Much of rapamycin's purported longevity benefits come from animal studies, lacking solid human evidence.
- Nuances:
- Rapamycin inhibits mTOR, a protein complex related to aging.
- Inhibition of mTOR is theorized to promote longevity by enhancing autophagy.
- Potential side effects include immune suppression and metabolic disruptions.
- Impact on Life: While rapamycin may not extend human lifespan, it could impact life by posing health risks such as immune suppression.
Investments
- Price:
- Time:
- Effort: Understanding potential side effects and scientific limitations.
Risks
Long-term use can suppress the immune system, increasing infection risk.
Alternatives
- Consider non-drug methods like diet and lifestyle changes to influence longevity.
Get Started 🚀
- Research the role of mTOR in aging and rapamycin's effects.
- Consult with healthcare professionals about longevity strategies.
- Consider lifestyle changes that naturally modulate mTOR activity.
Brogevity AI can make mistakes. Check important info.